Sanofi sales and marketing update

Sanofi launched LeGoo gel in the U.S. for temporary endovascular occlusion of blood vessels during surgical procedures. The pharma acquired the product through its 2012 acquisition of Pluromed Inc. LeGoo, which uses Pluromed's Rapid Transition Polymers (RTP) thermosensitive polymer technology, will cost $600 per kit, which company said should cover a single procedure (see BioCentury, March 19, 2012). ...